Primary study · included by 1 review
Parity and bladder cancer risk: a dose-response meta-analysis.
Bai 2017 · Bai Yunjin, Wang Xiaoming, Yang Yubo, et al. · BMC cancer · 2017
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.79 | NR | GRADE not reported |
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.76 [0.70, 0.82] | 13 studies · 2699564 participants | Low |
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.82 | NR | GRADE not reported |
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.76 | NR | GRADE not reported |
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.47 | NR | GRADE not reported |
Risk of bladder cancer Higher tooth loss vs Lower tooth loss | RR 1.23 [1.12, 1.35] | 2 studies · 64095 participants | Low |
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.68 | NR | GRADE not reported |
Risk of bladder cancer Ever parity (has given birth) vs Nulliparity (never given birth) | RR 0.78 | NR | GRADE not reported |
1 including review in total.